Potassium-enriched salt shows promise for cutting recurrent stroke risk in clinical trial

Potassium supplements in salt were associated with reduced rates of recurrent stroke and mortality in a large-scale cluster randomized clinical trial involving patients in rural northern China. Findings come from a subgroup (stroke patients) analysis within the original Salt Substitute and Stroke Study (SSaSS), an international study conducted in China.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup